This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Griffith University, Nationwide Children's Hospital, The University of Adelaide. Active years: 2022-2026.
Company Filing History:
2 out of 36 
1 out of 179 
1 out of 37 
Years Active: 2022-2026
Title: Christopher J Day - Innovator in Pathogen Modulation
Introduction
Christopher J Day is an inventor based in Nathan, Queensland, Australia. He has made significant contributions to the field of pathogen modulation through his research and innovative approaches. Although he currently holds no granted patents, his work is noteworthy for its potential impact on treating infections.
Latest Patent Applications
Christopher J Day's latest patent application is titled "Agents and Methods for Modulating Pathogen Activity." This application relates to the use of ligands of complement receptor 3, including ligands of the I domain of the alpha subunit of this receptor. The methods, compositions, and devices described aim to inhibit the interaction of pathogens with complement receptor 3-expressing cells, thereby treating or preventing infections caused by such pathogens.
Conclusion
Christopher J Day's innovative research in pathogen modulation highlights his commitment to advancing medical science, even in the absence of granted patents. His work has the potential to contribute significantly to the field of infectious disease treatment.